Incidence, attributable mortality, and healthcare and out-of-pocket costs of Clostridioides difficile infection in US Medicare Advantage Enrollees

Authors

Holly Yu, Pfizer Inc.
Tamuno Alfred, Pfizer Inc.
Jennifer L Nguyen, Pfizer Inc.
Jingying Zhou, Pfizer Inc.
Margaret A Olsen, Washington University School of Medicine in St. Louis

Journal

Clinical infectious diseases

Publication Date

2-8-2023

Volume

76

Issue

3

First Page

e1476

Last Page

e1483

Document Type

Open Access Publication

DOI

10.1093/cid/ciac467

Rights and Permissions

Holly Yu, Tamuno Alfred, Jennifer L Nguyen, Jingying Zhou, Margaret A Olsen, Incidence, Attributable Mortality, and Healthcare and Out-of-Pocket Costs of Clostridioides difficile Infection in US Medicare Advantage Enrollees, Clinical Infectious Diseases, Volume 76, Issue 3, 1 February 2023, Pages e1476–e1483, https://doi.org/10.1093/cid/ciac467. © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.

Recommended Citation

Yu, Holly; Alfred, Tamuno; Nguyen, Jennifer L; Zhou, Jingying; and Olsen, Margaret A, "Incidence, attributable mortality, and healthcare and out-of-pocket costs of Clostridioides difficile infection in US Medicare Advantage Enrollees." Clinical infectious diseases. 76, 3. e1476 - e1483. (2023).
https://digitalcommons.wustl.edu/oa_4/1191

Additional Links

Supplemental material is available for this article at publisher site.